A Cluster Sequencing Strategy To Determine the Consensus Affinity Domains in Heparin for Its Binding to Specific Proteins.

Glycosaminoglycans (GAGs) have high negative charge and are biologically and pharmaceutically important because their high charge promotes a strong interaction with many proteins. Due to the inherent heterogeneity of GAGs, multiple oligosaccharides, containing certain common domains, often can interact with clusters of basic amino acid residues on a target protein. The specificity of many GAG-protein interactions remains undiscovered since there is insufficient structural information on the interacting GAGs. Herein, we establish a cluster sequencing strategy to simultaneously deduce all major sequences of the affinity GAG oligosaccharides, leading to a definition of the consensus sequence they share that corresponds to the specific binding domain for the target protein. As a proof of concept, antithrombin III-binding oligosaccharides were examined, resulting in a heptasaccharide domain containing the well-established anticoagulant pentasaccharide sequence. Repeating this approach, a new pentasaccharide domain was discovered corresponding to the heparin motif responsible for binding interferon-γ (IFNγ). Our strategy is fundamentally important for the discovery of saccharide sequences needed in the development of novel GAG-based therapeutics.

[1]  Joshua A. Klein,et al.  GAGrank: Software for Glycosaminoglycan Sequence Ranking Using a Bipartite Graph Model , 2021, Molecular & cellular proteomics : MCP.

[2]  R. Linhardt,et al.  Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure , 2020, Science Translational Medicine.

[3]  Xin Liu,et al.  Oligosaccharides mapping of nitrous acid degraded heparin through UHPLC-HILIC/WAX-MS. , 2020, Carbohydrate polymers.

[4]  Lan Jin,et al.  The Role of Heparin/Heparan Sulphate in the IFN-γ-led Arena. , 2019, Biochimie.

[5]  Xin Liu,et al.  Characterization of epimerization and composition of heparin and dalteparin using a UHPLC-ESI-MS/MS method. , 2019, Carbohydrate polymers.

[6]  T. Wight A role for proteoglycans in vascular disease. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[7]  L. Kjellén,et al.  Specificity of glycosaminoglycan-protein interactions. , 2018, Current opinion in structural biology.

[8]  R. Linhardt,et al.  Sequencing the oligosaccharide pool in the low molecular weight heparin dalteparin with offline HPLC and ESI-MS/MS. , 2018, Carbohydrate polymers.

[9]  R. Kozar,et al.  Syndecan‐1 limits the progression of liver injury and promotes liver repair in acetaminophen‐induced liver injury in mice , 2017, Hepatology.

[10]  R. Woods,et al.  Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate. , 2017, Journal of the American Chemical Society.

[11]  M. Ishihara,et al.  Integrated Approach to Identify Heparan Sulfate Ligand Requirements of Robo1. , 2016, Journal of the American Chemical Society.

[12]  Roger L. Williams,et al.  The US regulatory and pharmacopeia response to the global heparin contamination crisis , 2016, Nature Biotechnology.

[13]  R. Linhardt,et al.  Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin. , 2016, Journal of pharmaceutical sciences.

[14]  W. Weitschies,et al.  Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4. , 2014, Blood.

[15]  G. Torri,et al.  Antithrombin-binding oligosaccharides: structural diversities in a unique function? , 2014, Glycoconjugate Journal.

[16]  A. Imberty,et al.  Insights into the mechanism by which interferon-γ basic amino acid clusters mediate protein binding to heparan sulfate. , 2013, Journal of the American Chemical Society.

[17]  Robert J Linhardt,et al.  Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS. , 2012, Analytical Chemistry.

[18]  R. Linhardt,et al.  Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation. , 2012, Analytical chemistry.

[19]  M. Nugent,et al.  A Computational Approach for Deciphering the Organization of Glycosaminoglycans , 2010, PloS one.

[20]  J. Leary,et al.  Heparin sequencing using enzymatic digestion and ESI-MSn with HOST: a heparin/HS oligosaccharide sequencing tool. , 2005, Analytical chemistry.

[21]  R. Linhardt,et al.  Heparin-protein interactions. , 2002, Angewandte Chemie.

[22]  Z. Shriver,et al.  Sequencing complex polysaccharides. , 1999, Science.

[23]  H. Lortat-Jacob,et al.  The Heparan Sulfate Binding Sequence of Interferon-γ Increased the On Rate of the Interferon-γ-Interferon-γ Receptor Complex Formation* , 1998, The Journal of Biological Chemistry.

[24]  A. Shvartsburg,et al.  An exact hard-spheres scattering model for the mobilities of polyatomic ions , 1996 .

[25]  George C. Schatz,et al.  Structural Information from Ion Mobility Measurements: Effects of the Long-Range Potential , 1996 .